Sanofi and GlaxoSmithKline Snag a $2.1 Billion Contract for Their Coronavirus Vaccine

Sanofi and GlaxoSmithKline Snag a $2.1 Billion Contract for Their Coronavirus Vaccine

Motley Fool

Published

The U.S. government is supporting development and manufacturing of the coronavirus vaccine in exchange for 100 million doses.

Full Article